Atlantic Coastal Acquisition Corp. II Files DEFA14A Proxy
Ticker: ABPWW · Form: DEFA14A · Filed: Sep 16, 2024 · CIK: 1893219
Sentiment: neutral
Topics: proxy-filing, sec-filing, supplemental-materials
TL;DR
ACQ filed more proxy docs, likely for a shareholder vote. Stay tuned.
AI Summary
Atlantic Coastal Acquisition Corp. II (ACQ) has filed a Definitive Additional Materials proxy statement (DEFA14A) on September 16, 2024. This filing supplements a previous proxy statement related to a special meeting. The company is incorporated in Delaware and operates in the Biological Products sector.
Why It Matters
This filing indicates that Atlantic Coastal Acquisition Corp. II is providing additional materials to shareholders, likely related to upcoming corporate actions or decisions requiring shareholder approval.
Risk Assessment
Risk Level: low — This is a routine SEC filing (DEFA14A) providing supplemental proxy materials, not indicating immediate significant financial risk or opportunity.
Key Players & Entities
- Atlantic Coastal Acquisition Corp. II (company) — Registrant
- 0001193125-24-219662 (filing_id) — Accession Number
- 20240916 (date) — Filing Date
- DEFA14A (document_type) — Form Type
FAQ
What is the purpose of this DEFA14A filing?
This DEFA14A filing is for 'Definitive Additional Materials' and supplements a previous proxy statement for Atlantic Coastal Acquisition Corp. II, likely related to a special meeting.
When was this filing submitted to the SEC?
The filing was submitted on September 16, 2024.
What is the Central Index Key (CIK) for Atlantic Coastal Acquisition Corp. II?
The CIK for Atlantic Coastal Acquisition Corp. II is 0001893219.
What is the Standard Industrial Classification (SIC) code for Atlantic Coastal Acquisition Corp. II?
The SIC code is 2836, categorized under Biological Products (No Diagnostic Substances).
Where is Atlantic Coastal Acquisition Corp. II headquartered?
The company's business and mailing address is 6 St Johns Lane, Floor 5, New York, NY 10013.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-09-16 16:45:25
Filing Documents
- d867134ddefa14a.htm (DEFA14A) — 14KB
- 0001193125-24-219662.txt ( ) — 15KB
From the Filing
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Atlantic Coastal Acquisition Corp. II (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. ATLANTIC COASTAL ACQUISITION CORP. II 6 St Johns Lane, Floor 5 New York, NY 10013 SUPPLEMENT TO PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS To Be Held September 16, 2024 Explanatory Note On September 4, 2024, Atlantic Coastal Acquisition Corp. II, which we refer to as we, us, our, ACAB or the Company, filed a definitive proxy statement, which, as supplemented, we refer to as the Proxy Statement, for a special meeting, which we refer to as the Special Meeting, of stockholders of the Company to be held at 4:30 p.m. Eastern Time on September 16, 2024. This supplement, which we refer to as this Supplement, to the Proxy Statement supplements the Proxy Statement as filed and should be read in conjunction with the Proxy Statement and any other additional proxy materials we have filed. The purpose of this Supplement is to inform shareholders that the meeting was adjourned and will be reconvened on September 19, 2024 at 4:30 p.m. Eastern Time. THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT. EXCEPT AS SPECIFICALLY SUPPLEMENTED BY THE INFORMATION CONTAINED HEREIN, THIS SUPPLEMENT DOES NOT MODIFY ANY OTHER INFORMATION SET FORTH IN THE PROXY STATEMENT. Important Information There are no changes to the proposals to be acted upon at the Special Meeting, which are described in the Proxy Statement, or the proxy card you previously received. Except as amended or supplemented by the information contained in this Supplement, all information set forth in the Proxy Statement continues to apply and should be considered in voting your shares. This Supplement and the Proxy Statement are available on the SECs website at www.sec.gov. Whether or not you intend to be present at the Special Meeting of Stockholders, we urge you to vote or submit your proxy promptly. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 16, 2024 By Order of the Board of Directors /s/ Shahraab Ahmad Shahraab Ahmad Chairman and Chief Executive Officer 3